<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Weykamp F</submitter><funding>Deutsche Forschungsgemeinschaft</funding><pagination>101573</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11372804</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(9)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Superior sulcus tumors are frequently treated with neoadjuvant chemoradiation therapy (nCRT) followed by surgery via a trimodal approach. The INKA study evaluated the replacement of photon irradiation by carbon ion radiation therapy (C12-RT) in this regimen.&lt;h4>Methods and materials&lt;/h4>The prospective INKA study included patients with locally advanced non-small cell superior sulcus tumors (&lt;cN3 cM0). Patients received 2 cycles of cisplatin and vinorelbine as per local standard. During the second cycle, 39 Gy(Relative biological effectiveness (RBE)) of hypofractionated C12-RT in 13 fractions were applied. Surgery following fludeoxyglucose F18 positron emission tomography-computed tomography restaging was performed 2 weeks later. The primary endpoint was feasibility and safe</pubmed_abstract><journal>Advances in radiation oncology</journal><pubmed_title>Carbon Ion Beam Radiation Therapy as Part of a Trimodal Therapy for Non-small Cell Superior Sulcus Tumors: The INKA Study.</pubmed_title><pmcid>PMC11372804</pmcid><funding_grant_id>HE 2499/4-1</funding_grant_id><funding_grant_id>KFO214</funding_grant_id><pubmed_authors>Weykamp F</pubmed_authors><pubmed_authors>Schaub L</pubmed_authors><pubmed_authors>Schirmacher P</pubmed_authors><pubmed_authors>Thomas M</pubmed_authors><pubmed_authors>Debus J</pubmed_authors><pubmed_authors>Winter H</pubmed_authors><pubmed_authors>Haberkorn U</pubmed_authors><pubmed_authors>Ellerbrock M</pubmed_authors><pubmed_authors>Adeberg S</pubmed_authors><pubmed_authors>Eichhorn M</pubmed_authors><pubmed_authors>Herfarth K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Carbon Ion Beam Radiation Therapy as Part of a Trimodal Therapy for Non-small Cell Superior Sulcus Tumors: The INKA Study.</name><description>&lt;h4>Purpose&lt;/h4>Superior sulcus tumors are frequently treated with neoadjuvant chemoradiation therapy (nCRT) followed by surgery via a trimodal approach. The INKA study evaluated the replacement of photon irradiation by carbon ion radiation therapy (C12-RT) in this regimen.&lt;h4>Methods and materials&lt;/h4>The prospective INKA study included patients with locally advanced non-small cell superior sulcus tumors (&lt;cN3 cM0). Patients received 2 cycles of cisplatin and vinorelbine as per local standard. During the second cycle, 39 Gy(Relative biological effectiveness (RBE)) of hypofractionated C12-RT in 13 fractions were applied. Surgery following fludeoxyglucose F18 positron emission tomography-computed tomography restaging was performed 2 weeks later. The primary endpoint was feasibility and safe</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2025-04-22T05:34:19.929Z</modification><creation>2024-11-15T21:29:53.754Z</creation></dates><accession>S-EPMC11372804</accession><cross_references><pubmed>39234234</pubmed><doi>10.1016/j.adro.2024.101573</doi></cross_references></HashMap>